Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug administration, medicine-related toxicity, and taste preferences. It is essential that pediatric medicines are formulated to best suit a child's age, size, physiologic condition, and treatment requirements. Therefore, the pediatric drug and vasccines specially serve for children.
The global Pediatric Drugs and Vaccines market size is projected to reach US$ 176440 million by 2027, from US$ 104980 million in 2020, at a CAGR of 9.0% during 2021-2027.
In terms of production side, this report researches the Pediatric Drugs and Vaccines production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Pediatric Drugs and Vaccines by regions (countries) and by Application.
The global Pediatric Drugs and Vaccines market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Pediatric Drugs and Vaccines market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Pediatric Drugs and Vaccines markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Pediatric Drugs and Vaccines market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Pediatric Drugs and Vaccines market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Pediatric Drugs and Vaccines market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Pediatric Drugs and Vaccines market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Pediatric Drugs and Vaccines market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Pediatric Drugs and Vaccines market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Pediatric Drugs and Vaccines market by each application segment for the same period.
This report includes the following manufacturers:
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Takeda
Market Segment by Type
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Market Segment by Application
Newborn
Infant
Child
Research Methodology
To compile the detailed study of the global Pediatric Drugs and Vaccines market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Pediatric Drugs and Vaccines market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Pediatric Drugs and Vaccines market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
The global Pediatric Drugs and Vaccines market size is projected to reach US$ 176440 million by 2027, from US$ 104980 million in 2020, at a CAGR of 9.0% during 2021-2027.
In terms of production side, this report researches the Pediatric Drugs and Vaccines production capacity, value, ex-factory price, growth rate, market share by manufacturers, regions (or countries) and by Type.
In terms of consumption side, this report focuses on the consumption of Pediatric Drugs and Vaccines by regions (countries) and by Application.
The global Pediatric Drugs and Vaccines market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Pediatric Drugs and Vaccines market. These figures have been provided in terms of both revenue and volume for the period 2016-2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise Pediatric Drugs and Vaccines markets such as North America, Europe, China and Japan, etc. Key regions covered in the report are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E
For the period 2016-2027, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Pediatric Drugs and Vaccines market. For the period 2016-2021, it provides sales (consumption) analysis and forecast of different regional markets by each application as well as type segment in terms of volume.
Manufacturers
The report includes comprehensive company profiling of leading and emerging companies competing in the global Pediatric Drugs and Vaccines market. It provides a detailed list of players operating at a global level. The players have been listed according to the type of products they offer in the global Pediatric Drugs and Vaccines market and other factors. As part of the company profiling, the analysts authoring the report has provided the market entry year of each player considered for the research study. The report also offers extensive price, volume sales, and revenue analysis by the manufacturer at the global level for the period 2016-2021.
By Type and Application Segments
The report includes a detailed analysis of leading and type and application segments of the global Pediatric Drugs and Vaccines market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue sales analysis and forecast of the global Pediatric Drugs and Vaccines market by each type segment for the period 2016-2027. It also offers volume sales (consumption) analysis and forecast of the global Pediatric Drugs and Vaccines market by each type segment for the same period. Also, it provides volume sales (consumption) analysis and forecast of the global Pediatric Drugs and Vaccines market by each application segment for the same period.
This report includes the following manufacturers:
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Takeda
Market Segment by Type
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Market Segment by Application
Newborn
Infant
Child
Research Methodology
To compile the detailed study of the global Pediatric Drugs and Vaccines market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Pediatric Drugs and Vaccines market. LBI Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Pediatric Drugs and Vaccines market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Pediatric Drugs and Vaccines Market Size Growth Rate by Type
1.2.2 Diphtheria
1.2.3 Influenza
1.2.4 Hepatitis
1.2.5 Pneumococcal Diseases
1.2.6 Meningococcal Diseases
1.2.7 Mumps
1.2.8 Others
1.3 Market Segment by Application
1.3.1 Global Pediatric Drugs and Vaccines Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Newborn
1.3.3 Infant
1.3.4 Child
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Pediatric Drugs and Vaccines Market Size (2016-2027)
2.1.1 Global Pediatric Drugs and Vaccines Revenue (2016-2027)
2.1.2 Global Pediatric Drugs and Vaccines Sales (2016-2027)
2.2 Global Pediatric Drugs and Vaccines Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Pediatric Drugs and Vaccines Sales by Regions (2016-2021)
2.2.2 Global Pediatric Drugs and Vaccines Revenue by Regions (2016-2021)
2.3 Global Pediatric Drugs and Vaccines Market Size Forecast by Region
2.3.1 Global Pediatric Drugs and Vaccines Sales Forecast by Region (2022-2027)
2.3.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Region (2022-2027)
2.4 Global Top Pediatric Drugs and Vaccines Regions (Countries) Ranking by Market Size
2.5 Pediatric Drugs and Vaccines Industry Trends
2.5.1 Pediatric Drugs and Vaccines Market Trends
2.5.2 Pediatric Drugs and Vaccines Market Drivers
2.5.3 Pediatric Drugs and Vaccines Market Challenges
2.5.4 Pediatric Drugs and Vaccines Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Pediatric Drugs and Vaccines Manufacturers by Sales (2016-2021)
3.1.1 Global Pediatric Drugs and Vaccines Sales by Manufacturers (2016-2021)
3.1.2 Global Pediatric Drugs and Vaccines Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Pediatric Drugs and Vaccines Sales in 2020
3.2 Global Top Manufacturers Pediatric Drugs and Vaccines by Revenue
3.2.1 Global Pediatric Drugs and Vaccines Revenue by Manufacturers (2016-2021)
3.2.2 Top Pediatric Drugs and Vaccines Manufacturers Covered: Ranking by Revenue
3.2.3 Global Pediatric Drugs and Vaccines Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Pediatric Drugs and Vaccines Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Drugs and Vaccines as of 2020)
3.4 Global Pediatric Drugs and Vaccines Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Pediatric Drugs and Vaccines Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Pediatric Drugs and Vaccines Market
3.7 Key Manufacturers Pediatric Drugs and Vaccines Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Pediatric Drugs and Vaccines Market Size by Type
4.1 Global Pediatric Drugs and Vaccines Historic Market Review by Type (2016-2021)
4.1.1 Global Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021)
4.1.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2016-2021)
4.1.3 Pediatric Drugs and Vaccines Price by Type (2016-2021)
4.2 Global Pediatric Drugs and Vaccines Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Pediatric Drugs and Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Pediatric Drugs and Vaccines Price Forecast by Type (2022-2027)
5 Global Pediatric Drugs and Vaccines Market Size by Application
5.1 Global Pediatric Drugs and Vaccines Historic Market Review by Application (2016-2021)
5.1.1 Global Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021)
5.1.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2016-2021)
5.1.3 Pediatric Drugs and Vaccines Price by Application (2016-2021)
5.2 Global Pediatric Drugs and Vaccines Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Pediatric Drugs and Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Pediatric Drugs and Vaccines Price Forecast by Application (2022-2027)
6 North America
6.1 North America Pediatric Drugs and Vaccines Sales Breakdown by Company
6.1.1 North America Pediatric Drugs and Vaccines Sales by Company (2016-2027)
6.1.2 North America Pediatric Drugs and Vaccines Revenue by Company (2016-2027)
6.2 North America Pediatric Drugs and Vaccines Market Size by Type (2016-2027)
6.2.1 North America Pediatric Drugs and Vaccines Sales by Type (2016-2027)
6.2.2 North America Pediatric Drugs and Vaccines Revenue by Type (2016-2027)
6.3 North America Pediatric Drugs and Vaccines Market Size by Application (2016-2027)
6.3.1 North America Pediatric Drugs and Vaccines Sales by Application (2016-2027)
6.3.2 North America Pediatric Drugs and Vaccines Revenue by Application (2016-2027)
6.4 North America Pediatric Drugs and Vaccines Market Size by Country
6.4.1 North America Pediatric Drugs and Vaccines Sales by Country (2016-2027)
6.4.2 North America Pediatric Drugs and Vaccines Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Pediatric Drugs and Vaccines Sales Breakdown by Company
7.1.1 Europe Pediatric Drugs and Vaccines Sales by Company (2016-2027)
7.1.2 Europe Pediatric Drugs and Vaccines Revenue by Company (2016-2027)
7.2 Europe Pediatric Drugs and Vaccines Market Size by Type (2016-2027)
7.2.1 Europe Pediatric Drugs and Vaccines Sales by Type (2016-2027)
7.2.2 Europe Pediatric Drugs and Vaccines Revenue by Type (2016-2027)
7.3 Europe Pediatric Drugs and Vaccines Market Size by Application (2016-2027)
7.3.1 Europe Pediatric Drugs and Vaccines Sales by Application (2016-2027)
7.3.2 Europe Pediatric Drugs and Vaccines Revenue by Application (2016-2027)
7.4 Europe Pediatric Drugs and Vaccines Market Size by Country
7.4.1 Europe Pediatric Drugs and Vaccines Sales by Country (2016-2027)
7.4.2 Europe Pediatric Drugs and Vaccines Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pediatric Drugs and Vaccines Sales Breakdown by Company
8.1.1 Asia Pacific Pediatric Drugs and Vaccines Sales by Company (2016-2027)
8.1.2 Asia Pacific Pediatric Drugs and Vaccines Revenue by Company (2016-2027)
8.2 Asia Pacific Pediatric Drugs and Vaccines Market Size by Type (2016-2027)
8.2.1 Asia Pacific Pediatric Drugs and Vaccines Sales by Type (2016-2027)
8.2.2 Asia Pacific Pediatric Drugs and Vaccines Revenue by Type (2016-2027)
8.3 Asia Pacific Pediatric Drugs and Vaccines Market Size by Application (2016-2027)
8.3.1 Asia Pacific Pediatric Drugs and Vaccines Sales by Application (2016-2027)
8.3.2 Asia Pacific Pediatric Drugs and Vaccines Revenue by Application (2016-2027)
8.4 Asia Pacific Pediatric Drugs and Vaccines Market Size by Regions
8.4.1 Asia Pacific Pediatric Drugs and Vaccines Sales by Regions
8.4.2 Asia Pacific Pediatric Drugs and Vaccines Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Pediatric Drugs and Vaccines Sales Breakdown by Company
9.1.1 Latin America Pediatric Drugs and Vaccines Sales by Company (2016-2027)
9.1.2 Latin America Pediatric Drugs and Vaccines Revenue by Company (2016-2027)
9.2 Latin America Pediatric Drugs and Vaccines Market Size by Type (2016-2027)
9.2.1 Latin America Pediatric Drugs and Vaccines Sales by Type (2016-2027)
9.2.2 Latin America Pediatric Drugs and Vaccines Revenue by Type (2016-2027)
9.3 Latin America Pediatric Drugs and Vaccines Market Size by Application (2016-2027)
9.3.1 Latin America Pediatric Drugs and Vaccines Sales by Application (2016-2027)
9.3.2 Latin America Pediatric Drugs and Vaccines Revenue by Application (2016-2027)
9.4 Latin America Pediatric Drugs and Vaccines Market Size by Country
9.4.1 Latin America Pediatric Drugs and Vaccines Sales by Country (2016-2027)
9.4.2 Latin America Pediatric Drugs and Vaccines Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pediatric Drugs and Vaccines Sales Breakdown by Company
10.1.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Company (2016-2027)
10.1.2 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Company (2016-2027)
10.2 Middle East and Africa Pediatric Drugs and Vaccines Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Type (2016-2027)
10.2.2 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Type (2016-2027)
10.3 Middle East and Africa Pediatric Drugs and Vaccines Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Application (2016-2027)
10.3.2 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Application (2016-2027)
10.4 Middle East and Africa Pediatric Drugs and Vaccines Market Size by Country
10.4.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Country (2016-2027)
10.4.2 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Merck & Co., Inc. (USA)
11.1.1 Merck & Co., Inc. (USA) Corporation Information
11.1.2 Merck & Co., Inc. (USA) Overview
11.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Products and Services
11.1.5 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines SWOT Analysis
11.1.6 Merck & Co., Inc. (USA) Recent Developments
11.2 Abbott Laboratories (USA)
11.2.1 Abbott Laboratories (USA) Corporation Information
11.2.2 Abbott Laboratories (USA) Overview
11.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Products and Services
11.2.5 Abbott Laboratories (USA) Pediatric Drugs and Vaccines SWOT Analysis
11.2.6 Abbott Laboratories (USA) Recent Developments
11.3 Amgen, Inc. (USA)
11.3.1 Amgen, Inc. (USA) Corporation Information
11.3.2 Amgen, Inc. (USA) Overview
11.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Products and Services
11.3.5 Amgen, Inc. (USA) Pediatric Drugs and Vaccines SWOT Analysis
11.3.6 Amgen, Inc. (USA) Recent Developments
11.4 Eli Lilly and Company (USA)
11.4.1 Eli Lilly and Company (USA) Corporation Information
11.4.2 Eli Lilly and Company (USA) Overview
11.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Products and Services
11.4.5 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines SWOT Analysis
11.4.6 Eli Lilly and Company (USA) Recent Developments
11.5 F. Hoffmann-La Roche Ltd (Switzerland)
11.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Corporation Information
11.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Overview
11.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Products and Services
11.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines SWOT Analysis
11.5.6 F. Hoffmann-La Roche Ltd (Switzerland) Recent Developments
11.6 Genentech, Inc. (USA)
11.6.1 Genentech, Inc. (USA) Corporation Information
11.6.2 Genentech, Inc. (USA) Overview
11.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Products and Services
11.6.5 Genentech, Inc. (USA) Pediatric Drugs and Vaccines SWOT Analysis
11.6.6 Genentech, Inc. (USA) Recent Developments
11.7 GlaxoSmithKline plc. (UK)
11.7.1 GlaxoSmithKline plc. (UK) Corporation Information
11.7.2 GlaxoSmithKline plc. (UK) Overview
11.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Products and Services
11.7.5 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines SWOT Analysis
11.7.6 GlaxoSmithKline plc. (UK) Recent Developments
11.8 Janssen Biologics B.V. (USA)
11.8.1 Janssen Biologics B.V. (USA) Corporation Information
11.8.2 Janssen Biologics B.V. (USA) Overview
11.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Products and Services
11.8.5 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines SWOT Analysis
11.8.6 Janssen Biologics B.V. (USA) Recent Developments
11.9 Actelion Pharmaceuticals
11.9.1 Actelion Pharmaceuticals Corporation Information
11.9.2 Actelion Pharmaceuticals Overview
11.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Products and Services
11.9.5 Actelion Pharmaceuticals Pediatric Drugs and Vaccines SWOT Analysis
11.9.6 Actelion Pharmaceuticals Recent Developments
11.10 AstraZeneca Plc. (UK)
11.10.1 AstraZeneca Plc. (UK) Corporation Information
11.10.2 AstraZeneca Plc. (UK) Overview
11.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Products and Services
11.10.5 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines SWOT Analysis
11.10.6 AstraZeneca Plc. (UK) Recent Developments
11.11 Boehringer Ingelheim GmbH (Germany)
11.11.1 Boehringer Ingelheim GmbH (Germany) Corporation Information
11.11.2 Boehringer Ingelheim GmbH (Germany) Overview
11.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.11.4 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Products and Services
11.11.5 Boehringer Ingelheim GmbH (Germany) Recent Developments
11.12 Bristol-Myers Squibb Company (USA)
11.12.1 Bristol-Myers Squibb Company (USA) Corporation Information
11.12.2 Bristol-Myers Squibb Company (USA) Overview
11.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.12.4 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Products and Services
11.12.5 Bristol-Myers Squibb Company (USA) Recent Developments
11.13 Allergan, Inc. (USA)
11.13.1 Allergan, Inc. (USA) Corporation Information
11.13.2 Allergan, Inc. (USA) Overview
11.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.13.4 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Products and Services
11.13.5 Allergan, Inc. (USA) Recent Developments
11.14 Novartis AG (Switzerland)
11.14.1 Novartis AG (Switzerland) Corporation Information
11.14.2 Novartis AG (Switzerland) Overview
11.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.14.4 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Products and Services
11.14.5 Novartis AG (Switzerland) Recent Developments
11.15 Novo Nordisk A/S (Denmark)
11.15.1 Novo Nordisk A/S (Denmark) Corporation Information
11.15.2 Novo Nordisk A/S (Denmark) Overview
11.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.15.4 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Products and Services
11.15.5 Novo Nordisk A/S (Denmark) Recent Developments
11.16 Pfizer, Inc. (USA)
11.16.1 Pfizer, Inc. (USA) Corporation Information
11.16.2 Pfizer, Inc. (USA) Overview
11.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.16.4 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Products and Services
11.16.5 Pfizer, Inc. (USA) Recent Developments
11.17 Sanofi S.A (France)
11.17.1 Sanofi S.A (France) Corporation Information
11.17.2 Sanofi S.A (France) Overview
11.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.17.4 Sanofi S.A (France) Pediatric Drugs and Vaccines Products and Services
11.17.5 Sanofi S.A (France) Recent Developments
11.18 Shionogi Inc. (USA)
11.18.1 Shionogi Inc. (USA) Corporation Information
11.18.2 Shionogi Inc. (USA) Overview
11.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.18.4 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Products and Services
11.18.5 Shionogi Inc. (USA) Recent Developments
11.19 Takeda
11.19.1 Takeda Corporation Information
11.19.2 Takeda Overview
11.19.3 Takeda Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.19.4 Takeda Pediatric Drugs and Vaccines Products and Services
11.19.5 Takeda Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Pediatric Drugs and Vaccines Value Chain Analysis
12.2 Pediatric Drugs and Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pediatric Drugs and Vaccines Production Mode & Process
12.4 Pediatric Drugs and Vaccines Sales and Marketing
12.4.1 Pediatric Drugs and Vaccines Sales Channels
12.4.2 Pediatric Drugs and Vaccines Distributors
12.5 Pediatric Drugs and Vaccines Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Pediatric Drugs and Vaccines Market Size Growth Rate by Type
1.2.2 Diphtheria
1.2.3 Influenza
1.2.4 Hepatitis
1.2.5 Pneumococcal Diseases
1.2.6 Meningococcal Diseases
1.2.7 Mumps
1.2.8 Others
1.3 Market Segment by Application
1.3.1 Global Pediatric Drugs and Vaccines Market Share by Application (2016 VS 2021 VS 2027)
1.3.2 Newborn
1.3.3 Infant
1.3.4 Child
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Pediatric Drugs and Vaccines Market Size (2016-2027)
2.1.1 Global Pediatric Drugs and Vaccines Revenue (2016-2027)
2.1.2 Global Pediatric Drugs and Vaccines Sales (2016-2027)
2.2 Global Pediatric Drugs and Vaccines Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027
2.2.1 Global Pediatric Drugs and Vaccines Sales by Regions (2016-2021)
2.2.2 Global Pediatric Drugs and Vaccines Revenue by Regions (2016-2021)
2.3 Global Pediatric Drugs and Vaccines Market Size Forecast by Region
2.3.1 Global Pediatric Drugs and Vaccines Sales Forecast by Region (2022-2027)
2.3.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Region (2022-2027)
2.4 Global Top Pediatric Drugs and Vaccines Regions (Countries) Ranking by Market Size
2.5 Pediatric Drugs and Vaccines Industry Trends
2.5.1 Pediatric Drugs and Vaccines Market Trends
2.5.2 Pediatric Drugs and Vaccines Market Drivers
2.5.3 Pediatric Drugs and Vaccines Market Challenges
2.5.4 Pediatric Drugs and Vaccines Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Pediatric Drugs and Vaccines Manufacturers by Sales (2016-2021)
3.1.1 Global Pediatric Drugs and Vaccines Sales by Manufacturers (2016-2021)
3.1.2 Global Pediatric Drugs and Vaccines Sales Market Share by Manufacturers (2016-2021)
3.1.3 Global 5 and 10 Largest Manufacturers by Pediatric Drugs and Vaccines Sales in 2020
3.2 Global Top Manufacturers Pediatric Drugs and Vaccines by Revenue
3.2.1 Global Pediatric Drugs and Vaccines Revenue by Manufacturers (2016-2021)
3.2.2 Top Pediatric Drugs and Vaccines Manufacturers Covered: Ranking by Revenue
3.2.3 Global Pediatric Drugs and Vaccines Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Pediatric Drugs and Vaccines Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Drugs and Vaccines as of 2020)
3.4 Global Pediatric Drugs and Vaccines Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Pediatric Drugs and Vaccines Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Pediatric Drugs and Vaccines Market
3.7 Key Manufacturers Pediatric Drugs and Vaccines Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Pediatric Drugs and Vaccines Market Size by Type
4.1 Global Pediatric Drugs and Vaccines Historic Market Review by Type (2016-2021)
4.1.1 Global Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2021)
4.1.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2016-2021)
4.1.3 Pediatric Drugs and Vaccines Price by Type (2016-2021)
4.2 Global Pediatric Drugs and Vaccines Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Pediatric Drugs and Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Pediatric Drugs and Vaccines Price Forecast by Type (2022-2027)
5 Global Pediatric Drugs and Vaccines Market Size by Application
5.1 Global Pediatric Drugs and Vaccines Historic Market Review by Application (2016-2021)
5.1.1 Global Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2021)
5.1.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2016-2021)
5.1.3 Pediatric Drugs and Vaccines Price by Application (2016-2021)
5.2 Global Pediatric Drugs and Vaccines Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Pediatric Drugs and Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Pediatric Drugs and Vaccines Price Forecast by Application (2022-2027)
6 North America
6.1 North America Pediatric Drugs and Vaccines Sales Breakdown by Company
6.1.1 North America Pediatric Drugs and Vaccines Sales by Company (2016-2027)
6.1.2 North America Pediatric Drugs and Vaccines Revenue by Company (2016-2027)
6.2 North America Pediatric Drugs and Vaccines Market Size by Type (2016-2027)
6.2.1 North America Pediatric Drugs and Vaccines Sales by Type (2016-2027)
6.2.2 North America Pediatric Drugs and Vaccines Revenue by Type (2016-2027)
6.3 North America Pediatric Drugs and Vaccines Market Size by Application (2016-2027)
6.3.1 North America Pediatric Drugs and Vaccines Sales by Application (2016-2027)
6.3.2 North America Pediatric Drugs and Vaccines Revenue by Application (2016-2027)
6.4 North America Pediatric Drugs and Vaccines Market Size by Country
6.4.1 North America Pediatric Drugs and Vaccines Sales by Country (2016-2027)
6.4.2 North America Pediatric Drugs and Vaccines Revenue by Country (2016-2027)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Pediatric Drugs and Vaccines Sales Breakdown by Company
7.1.1 Europe Pediatric Drugs and Vaccines Sales by Company (2016-2027)
7.1.2 Europe Pediatric Drugs and Vaccines Revenue by Company (2016-2027)
7.2 Europe Pediatric Drugs and Vaccines Market Size by Type (2016-2027)
7.2.1 Europe Pediatric Drugs and Vaccines Sales by Type (2016-2027)
7.2.2 Europe Pediatric Drugs and Vaccines Revenue by Type (2016-2027)
7.3 Europe Pediatric Drugs and Vaccines Market Size by Application (2016-2027)
7.3.1 Europe Pediatric Drugs and Vaccines Sales by Application (2016-2027)
7.3.2 Europe Pediatric Drugs and Vaccines Revenue by Application (2016-2027)
7.4 Europe Pediatric Drugs and Vaccines Market Size by Country
7.4.1 Europe Pediatric Drugs and Vaccines Sales by Country (2016-2027)
7.4.2 Europe Pediatric Drugs and Vaccines Revenue by Country (2016-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pediatric Drugs and Vaccines Sales Breakdown by Company
8.1.1 Asia Pacific Pediatric Drugs and Vaccines Sales by Company (2016-2027)
8.1.2 Asia Pacific Pediatric Drugs and Vaccines Revenue by Company (2016-2027)
8.2 Asia Pacific Pediatric Drugs and Vaccines Market Size by Type (2016-2027)
8.2.1 Asia Pacific Pediatric Drugs and Vaccines Sales by Type (2016-2027)
8.2.2 Asia Pacific Pediatric Drugs and Vaccines Revenue by Type (2016-2027)
8.3 Asia Pacific Pediatric Drugs and Vaccines Market Size by Application (2016-2027)
8.3.1 Asia Pacific Pediatric Drugs and Vaccines Sales by Application (2016-2027)
8.3.2 Asia Pacific Pediatric Drugs and Vaccines Revenue by Application (2016-2027)
8.4 Asia Pacific Pediatric Drugs and Vaccines Market Size by Regions
8.4.1 Asia Pacific Pediatric Drugs and Vaccines Sales by Regions
8.4.2 Asia Pacific Pediatric Drugs and Vaccines Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Pediatric Drugs and Vaccines Sales Breakdown by Company
9.1.1 Latin America Pediatric Drugs and Vaccines Sales by Company (2016-2027)
9.1.2 Latin America Pediatric Drugs and Vaccines Revenue by Company (2016-2027)
9.2 Latin America Pediatric Drugs and Vaccines Market Size by Type (2016-2027)
9.2.1 Latin America Pediatric Drugs and Vaccines Sales by Type (2016-2027)
9.2.2 Latin America Pediatric Drugs and Vaccines Revenue by Type (2016-2027)
9.3 Latin America Pediatric Drugs and Vaccines Market Size by Application (2016-2027)
9.3.1 Latin America Pediatric Drugs and Vaccines Sales by Application (2016-2027)
9.3.2 Latin America Pediatric Drugs and Vaccines Revenue by Application (2016-2027)
9.4 Latin America Pediatric Drugs and Vaccines Market Size by Country
9.4.1 Latin America Pediatric Drugs and Vaccines Sales by Country (2016-2027)
9.4.2 Latin America Pediatric Drugs and Vaccines Revenue by Country (2016-2027)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pediatric Drugs and Vaccines Sales Breakdown by Company
10.1.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Company (2016-2027)
10.1.2 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Company (2016-2027)
10.2 Middle East and Africa Pediatric Drugs and Vaccines Market Size by Type (2016-2027)
10.2.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Type (2016-2027)
10.2.2 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Type (2016-2027)
10.3 Middle East and Africa Pediatric Drugs and Vaccines Market Size by Application (2016-2027)
10.3.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Application (2016-2027)
10.3.2 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Application (2016-2027)
10.4 Middle East and Africa Pediatric Drugs and Vaccines Market Size by Country
10.4.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Country (2016-2027)
10.4.2 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Country (2016-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Merck & Co., Inc. (USA)
11.1.1 Merck & Co., Inc. (USA) Corporation Information
11.1.2 Merck & Co., Inc. (USA) Overview
11.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Products and Services
11.1.5 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines SWOT Analysis
11.1.6 Merck & Co., Inc. (USA) Recent Developments
11.2 Abbott Laboratories (USA)
11.2.1 Abbott Laboratories (USA) Corporation Information
11.2.2 Abbott Laboratories (USA) Overview
11.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.2.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Products and Services
11.2.5 Abbott Laboratories (USA) Pediatric Drugs and Vaccines SWOT Analysis
11.2.6 Abbott Laboratories (USA) Recent Developments
11.3 Amgen, Inc. (USA)
11.3.1 Amgen, Inc. (USA) Corporation Information
11.3.2 Amgen, Inc. (USA) Overview
11.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.3.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Products and Services
11.3.5 Amgen, Inc. (USA) Pediatric Drugs and Vaccines SWOT Analysis
11.3.6 Amgen, Inc. (USA) Recent Developments
11.4 Eli Lilly and Company (USA)
11.4.1 Eli Lilly and Company (USA) Corporation Information
11.4.2 Eli Lilly and Company (USA) Overview
11.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.4.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Products and Services
11.4.5 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines SWOT Analysis
11.4.6 Eli Lilly and Company (USA) Recent Developments
11.5 F. Hoffmann-La Roche Ltd (Switzerland)
11.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Corporation Information
11.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Overview
11.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Products and Services
11.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines SWOT Analysis
11.5.6 F. Hoffmann-La Roche Ltd (Switzerland) Recent Developments
11.6 Genentech, Inc. (USA)
11.6.1 Genentech, Inc. (USA) Corporation Information
11.6.2 Genentech, Inc. (USA) Overview
11.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.6.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Products and Services
11.6.5 Genentech, Inc. (USA) Pediatric Drugs and Vaccines SWOT Analysis
11.6.6 Genentech, Inc. (USA) Recent Developments
11.7 GlaxoSmithKline plc. (UK)
11.7.1 GlaxoSmithKline plc. (UK) Corporation Information
11.7.2 GlaxoSmithKline plc. (UK) Overview
11.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.7.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Products and Services
11.7.5 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines SWOT Analysis
11.7.6 GlaxoSmithKline plc. (UK) Recent Developments
11.8 Janssen Biologics B.V. (USA)
11.8.1 Janssen Biologics B.V. (USA) Corporation Information
11.8.2 Janssen Biologics B.V. (USA) Overview
11.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.8.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Products and Services
11.8.5 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines SWOT Analysis
11.8.6 Janssen Biologics B.V. (USA) Recent Developments
11.9 Actelion Pharmaceuticals
11.9.1 Actelion Pharmaceuticals Corporation Information
11.9.2 Actelion Pharmaceuticals Overview
11.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.9.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Products and Services
11.9.5 Actelion Pharmaceuticals Pediatric Drugs and Vaccines SWOT Analysis
11.9.6 Actelion Pharmaceuticals Recent Developments
11.10 AstraZeneca Plc. (UK)
11.10.1 AstraZeneca Plc. (UK) Corporation Information
11.10.2 AstraZeneca Plc. (UK) Overview
11.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.10.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Products and Services
11.10.5 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines SWOT Analysis
11.10.6 AstraZeneca Plc. (UK) Recent Developments
11.11 Boehringer Ingelheim GmbH (Germany)
11.11.1 Boehringer Ingelheim GmbH (Germany) Corporation Information
11.11.2 Boehringer Ingelheim GmbH (Germany) Overview
11.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.11.4 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Products and Services
11.11.5 Boehringer Ingelheim GmbH (Germany) Recent Developments
11.12 Bristol-Myers Squibb Company (USA)
11.12.1 Bristol-Myers Squibb Company (USA) Corporation Information
11.12.2 Bristol-Myers Squibb Company (USA) Overview
11.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.12.4 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Products and Services
11.12.5 Bristol-Myers Squibb Company (USA) Recent Developments
11.13 Allergan, Inc. (USA)
11.13.1 Allergan, Inc. (USA) Corporation Information
11.13.2 Allergan, Inc. (USA) Overview
11.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.13.4 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Products and Services
11.13.5 Allergan, Inc. (USA) Recent Developments
11.14 Novartis AG (Switzerland)
11.14.1 Novartis AG (Switzerland) Corporation Information
11.14.2 Novartis AG (Switzerland) Overview
11.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.14.4 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Products and Services
11.14.5 Novartis AG (Switzerland) Recent Developments
11.15 Novo Nordisk A/S (Denmark)
11.15.1 Novo Nordisk A/S (Denmark) Corporation Information
11.15.2 Novo Nordisk A/S (Denmark) Overview
11.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.15.4 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Products and Services
11.15.5 Novo Nordisk A/S (Denmark) Recent Developments
11.16 Pfizer, Inc. (USA)
11.16.1 Pfizer, Inc. (USA) Corporation Information
11.16.2 Pfizer, Inc. (USA) Overview
11.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.16.4 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Products and Services
11.16.5 Pfizer, Inc. (USA) Recent Developments
11.17 Sanofi S.A (France)
11.17.1 Sanofi S.A (France) Corporation Information
11.17.2 Sanofi S.A (France) Overview
11.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.17.4 Sanofi S.A (France) Pediatric Drugs and Vaccines Products and Services
11.17.5 Sanofi S.A (France) Recent Developments
11.18 Shionogi Inc. (USA)
11.18.1 Shionogi Inc. (USA) Corporation Information
11.18.2 Shionogi Inc. (USA) Overview
11.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.18.4 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Products and Services
11.18.5 Shionogi Inc. (USA) Recent Developments
11.19 Takeda
11.19.1 Takeda Corporation Information
11.19.2 Takeda Overview
11.19.3 Takeda Pediatric Drugs and Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)
11.19.4 Takeda Pediatric Drugs and Vaccines Products and Services
11.19.5 Takeda Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Pediatric Drugs and Vaccines Value Chain Analysis
12.2 Pediatric Drugs and Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pediatric Drugs and Vaccines Production Mode & Process
12.4 Pediatric Drugs and Vaccines Sales and Marketing
12.4.1 Pediatric Drugs and Vaccines Sales Channels
12.4.2 Pediatric Drugs and Vaccines Distributors
12.5 Pediatric Drugs and Vaccines Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
